Global Acute Myeloid Leukemia Treatment Market Size & Outlook
The acute myeloid leukemia treatment industry worldwide is expected to reach a projected revenue of US$ 6,292.1 million by 2030. A compound annual growth rate of 10.2% is expected of the worldwide acute myeloid leukemia treatment industry from 2024 to 2030.
Revenue, 2023 (US$M)
$3,179.5
Forecast, 2030 (US$M)
$6,292.1
CAGR, 2024 - 2030
10.2%
Report Coverage
Worldwide
Global acute myeloid leukemia treatment market, 2018-2030 (US$M)
Related Markets
Global acute myeloid leukemia treatment market highlights
- The global acute myeloid leukemia treatment market generated a revenue of USD 3,179.5 million in 2023 and is expected to reach USD 6,292.1 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 10.2% by 2030.
- In terms of segment, myeloblastic leukemia accounted for a revenue of USD 3,179.5 million in 2023.
- Myeloblastic Leukemia is the most lucrative disease segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
Global data book summary
| Market revenue in 2023 | USD 3,179.5 million |
| Market revenue in 2030 | USD 6,292.1 million |
| Growth rate | 10.2% (CAGR from 2023 to 2030) |
| Largest segment | Myeloblastic leukemia |
| Fastest growing segment | Myeloblastic Leukemia |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Myeloblastic Leukemia |
Other key industry trends
- In terms of revenue, the North America accounted for 37.7% of the global acute myeloid leukemia treatment market in 2023.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Acute Myeloid Leukemia Treatment Market Scope
Acute myeloid leukemia treatment market segmentation & scope
Myeloblastic Leukemia
Myelomonocytic Leukemia
Promyelocytic Leukemia
Monocytic Leukemia
Other Diseases
Treatment
Chemotherapy
Targeted Therapy
Immunotherapy
Other Treatments
Route of Administration
Parenteral
Oral
End Use
Hospitals and Clinics
Specialty Centers
Homecare Setting
Ambulatory Care Centers
Countries
U.S.
Canada
Mexico
Denmark
France
Germany
Italy
Norway
Spain
Sweden
UK
China
India
Japan
South Korea
Thailand
Australia
Brazil
Argentina
UAE
South Africa
Saudi Arabia
Kuwait
Acute Myeloid Leukemia Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global acute myeloid leukemia treatment market size, by regions, 2018-2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
